blood pressure
The FDA claims the wearable tech company's BPI offering is "adulterated" and "misbranded," and is being sold without the proper regulatory approvals.
The monitor aims to simplify clinical workflows, automate patient engagement and allow for patient-reported outcomes collection.
The aim is to deliver clinical insights and improve patient engagement.
Despite a dry investment climate, it was able to secure what could be the biggest funding raise by a health tech company in South Korea this year.
The cuffless device uses a sensor array over the radial artery to produce a pressure waveform that's used to determine systolic and diastolic blood pressure.
Also, I-MED will expand its deployment of 4DMedical's lung imaging tool across its network in Australia.
The non-prick device can measure blood glucose and monitor blood pressure without pressure cuffs.
This new infusion of cash brings the company's total funding to $28 million.
The study enrolled more than 28,000 participants, and the follow-up period lasted as long as three years.